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Mice transgenic for y2b Ig heavy chain were examined for alterations in B-cell differentiation
and endogenous Ig gene rearrangement and expression. Fresh bone marrow from these mice
was markedly reduced in BP-1 cells and there were small reductions in B220 and sIg
cells. A-MuLV (Abelson murine leukemia virus) transformants from these bone marrow cells
showed little alteration in Ig gene rearrangement and expression when compared to
controls, however. Isolation of the B-lymphoid compartment from these mice in vitro using
LBMC (lymphoid bone marrow cultures) enabled more detailed characterization of the
effects of the transgene. LBMC derived from y2b transgenic mice had similar growth
kinetics, but a 4-5-week delay in the expression of endogenous mu Ig in comparison to
control cultures. Nucleic acids derived from these early cultures prior to endogenous mu Ig
expression showed reduced Ig JH rearrangements, some sterile mu transcription, low levels
of BP-1 expression, and virtually undetectable TdT (terminal deoxynucleotidyl transferase)
expression. Thus, this y2b transgene appears able to affect early B-lymphocyte development.
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INTRODUCTION
Mice transgenic for immunoglobulin genes have
been utilized to study the control of expression of
these genes as well as the regulation of the encoded
antibody molecules (reviewed in Storb, 1988). In
addition to specific effects upon endogenous Ig
genes, transgenes can exert more global influences
on early B-lymphocyte development. Two different
lines of mice transgenic for mu heavy-chain genes
have been shown to lack the major population of
bone marrow derived B cells (Herzenberg et al.,
1987) or have an altered pre-B-cell compartment
(Nussenzweig et al., 1988), indicating a perturbation
in early B-cell development.
We haee investigated the nature of the changes in
the early B-lymphocyte lineage cells in Ig y2B
heavy-chain transgenic mice (Tsang et al., 1988) by
*Corresponding author. Present address: Specialty Laboratories,
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evaluating this developmental compartment using
lymphoid bone marrow cultures (LBMC, Whitlock
and Witte, 1982; reviewed in Denis and Witte, 1989).
These cultures allow the study of B-lymphocyte
commitment and differentiation from a multi-
potential progenitor in vitro (Denis and Witte, 1986;
Dorshkind, 1986; Muller-Sieburg et al., 1986). Mice
transgenic for a functionally rearranged y2b Ig
heavy chain were utilized for these studies. Cells
expressing endogenous mu could be easily discri-
minated from those expressing the transgene,
obviating the need for allotypic analysis (Herzenberg
et al., 1987) or interspecies studies (Nussenzweig et
al., 1988).
These y2b transgenic mice were deficient in bone
marrow pre-B cells, much as has been shown with
other transgenic lines. LBMC established from these
mice demonstrated a delayed expression of endo-
genous Ig as well as delayed rearrangement at the
IgH locus when compared to control cultures. Des-
pite the presence of transcription at the IgH locus,
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terminal deoxynucleotidyl transferase (Alt and Balti-
more, 1982; Landau et al., 1987) expression was
markedly reduced. The transcription of another early
B-lymphocyte-development molecule, BP-1 (Cooper
et al., 1986), was also reduced in these cultures. The
presence of this y2b transgene may affect B-lympho-
cyte differentiation as well as Ig recombination.
RESULTS
The Bone Marrow of y2b Transgenic Mice Has a
Significantly Reduced Pre-B-Cell Compartment
Bone marrow cells of y2b transgenic mice were
examined by flow cytometry to define their
lymphoid composition in comparison to that of bone
marrow from normal li.ttermates. Fresh femoral bone
marrow was harvested from these mice and stained
with FITC-labeled reagents for sIgM, sIgG2b, B220
(Kincade, 1981) and BP-1 (Cooper et al., 1986).
These markers were chosen to give an overview of
the B-cell-differentiation stages present. B220 is
expressed by almost all B-lymphoid cells (Kincade et
al., 1989), whereas BP-1 (equivalent to 6C3; Wu et
al., 1989) is present only on late B precursors and
pre-B cells in the bone marrow. The more mature
B-cell population expresses sIgM while sIgG2b
expression is rare in normal bone marrow, but
present in a subpopulation of B cells transgenic for
the y2b heavy chain. As summarized in Table 1, the
bone marrow cells from the y2b transgenic mice had
decreased expression of the B-lineage markers, BP-1,
B220, and sIgM. The sIgM + and B220+ cells are
two-fold reduced in the bone marrow of these trans-
genic mice, but the largest perturbation is in the
BP-1 + population. These early B-lymphoid cells are
reduced five- to ten-fold in the y2b transgenic
mouse bone marrow.
TABLE 1
Cell-Surface Staining of Bone Marrow from y2b Transgenic Mice
and Normal Litermates
Normal Transgenic
BP-1 13.5% (12-15) 2.0% (1-3)
B220 20.3% (19-22) 14.3% (12-16)
IgM 12.5% (9-15) 4.3% (2-6)
IgG2b 1.2% (0.5-2) 5.0% (4-6)
’Data are presented as the mean (range) of three independent experi-
ments. Fresh bone marrow from mice to ’10 weeks of age was stained
directly with FITC-labeled antimouse IgM or antimouse IgG2b (Southern
Biotech, Birmingham, AL) or indirectly with BP-1 (generously provided by
Dr. M. D. Cooper) or B220 (14.8) followed by F1TC-labeled antimouse
lgG2a or antirat lg, respectively. Cells were analyzed on a Coulter Epics.
To further analyze the early B-lymphoid Compart-
ment of these mice, cell lines were derived by a
A-MuLV transformation and single-cell cloning of
bone marrow. As seen in Table 2, only a slight
reduction of A-MuLV target cells was observed in
the y2b transgenic mouse bone marrow. This is not
surprising, as the vast majority of A-MuLV target
cells in normal bone marrow are BP-1 (6C3) negative
but B220 + (Tidmarsh et al. 1989). By using meta-
bolic labeling followed by immunoprecipitation and
SDS-polyacrylamide gel electrophoresis to identify
the Ig chains synthesized by each cell line, it could
be shown that all of the cell lines derived from
transgenic mice were synthesizing gamma heavy
chain (Table 2). In addition, 2 of 12 of these lines
coexpressed mu and one of these also expressed
kappa. The cell lines derived from the bone marrow
of normal litter mates correlated well with the range
of Ig expression previously observed in A-MuLV-
transformed cells from normal bone marrow (Altet
al., 1981)with 40% mug 10% kappa+ and no
gamma + lines (Table 2).
TABLE 2
A-MuLV-Transformed Cell Lines Derived from the Bone Marrow
of y2b Transgenic Mice and Normal Littermates
Normal Transgenic
A-MuLV target
frequency 12.1 8.7
(per 106 cells)
Ig synthesized
gamma 0% 100%
mu 40% 17%
kappa 10% 8%
IgH Gene Configuration
E 0% 0%
DJ 15% 33%
VDJ 85% 58%
aFresh bone marrow was transformed with A-MuLV and cloned in agar
as previously described (Whitlock et al., 1983). Data are derived from the
analysis of 12 transgenic and 10 normal littermate-derived cell lines, as
described in the text. The lgH gene configuration is the percent of total
alleles; 2/24 alleles in the transgenic cell lines were deleted. A 5’ D probe
was used to differentiate DJ from VDJ rearrangements (Alt et al., 1984).
The IgH gene configuration of these cell lines was
also examined using a JH probe (Early et al., 1980), a
5’ of JH probe (Weaver et al., 1985) and a 5’D probe
(Alt et al., 1984). It has been demonstrated that the
initial event that takes place in the heavy-chain
locus is a D segment to J region rearrangement
event, and the presence of the 5’ JH region or the 5’D
region indicates that D-J or V-D rearrangement,EARLY B CELLS IN }/2b TRANSGENIC MICE 107
respectively, has not yet taken place (Alt et al.,
1984). By using these analyses, it was shown that all
cell lines had undergone at least D-J rearrangement
(Table 2). The transgenic cell lines had approxi-
mately twice as many D-J only rearrangements as
did the normal control. These results were in con-
trast to the finding of complete inhibition of endo-
genous D-J rearrangement seen in some pre-B cells
or in hybridomas of transgenic mice with membrane
terminus containing mu (Rusconi and Kohler, 1985;
Weaver et al., 1985; Nussenzweig et al., 1987; Manz
et al., 1988) or delta (Iglesias et al., 1987) transgenes.
However, over 30% of hybridomas from spleen B
cells of the same y2b transgenic mice show one
germline H allele (Roth and U.S., unpublished).
Thus, y2b can exert feedback inhibition of Ig gene
rearrangement (see what follows).
LBMC from y2b Transgenic Mice Have Delayed
Expression of Endogenous Ig
The slight perturbation of endogenous Ig gene re-
arrangement and expression seen in the A-MuLV
transformants from the y2b transgenic mice did not
appear to reflect the changes observed in the fresh
bone marrow. We therefore turned to LBMC to
isolate a wider spectrum of early B-lymphoid
development from the bone marrow of these mice.
Long-term lymphoid cultures (Whitlock and Witte,
1982; Whitlock et al., 1984) derived from the bone
marrow of y2b transgenic and normal littermates
appeared kinetically and morphologically similar in
the development of their adherent and nonadherent
cell compartments. After several weeks of culture,
both the transgenic and normal LBMC had confluent
lawns of nonadherent lymphoid cells of approxi-
mately the same cell density that were sampled and
examined for Ig synthesis by immunoperoxidase cell
staining. The lymphoid cells from the cultures estab-
lished from the bone marrow of the normal litter-
mates were an average of 13% positive for mu
heavy chain after 4 weeks of culture (Fig. 1) and
rose to 20-30% positive by 5--6 weeks of culture.
These values are very typical for LBMC established
from BALB/c bone marrow (Denis et al., 1984). No
expression of gamma heavy chain was seen in these
cultures. In contrast, the lymphoid cells from cul-
tures established from the bbne marrow of the y2b
transgenic mice were less than 1% positive for mu
heavy chain after 4 weeks of culture and did not
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FIGURE 1. Cytoplasmic Ig produc-
tion in cells from LBMC. Cytospin
preparations of cells from LBMC
derived from either y2b transgenic or
normal control mouse bone marrow
were made at weekly intervals. These
were stained with Ig-specific reagents,
as described in the text. The results
are the mean and standard deviation
of 6-12 culture dishes derived from
2-5 individual mice in each group.108 K.A. DENIS et al.
reach a level of more than 10% positive until 8
weeks of culture. During this time, the transgenic
y2b heavy chains were expressed by a majority of
the cells in the LBMC.
After 5 weeks of culture, when mu heavy-chain
production was very low in LBMC derived from y2b
transgenic mice, cells were harvested and DNA
extracted. This DNA was analyzed by Southern blot
for the presence of rearrangements at the JH locus.
Numerous rearrangements of the JH locus could be
seen in the DNA from the normal LBMC with loss
of intensity of the 6.2-kb germ-line fragment (Fig.
2). As a population, the LBMC derived from the y2b
transgenic mice showed a much greater proportion
of germ-line JH region fragment (Fig. 2, lane C). A
mu probe was used to demonstrate equivalent DNA
loading (data not shown). This would indicate that
the delay in mu Ig heavy-chain production is the
result of decreased rearrangement activity in the
transgenic bone marrow d’erived LBMC.
Following 8-10 weeks of culture, the levels of
endogenous Ig expressed by the normal and trans-
genic LBMC were approximately equal. To assess
the size and charge diversity of these Ig chains,
two-dimensional gel electrophoresis was performed.
The nonadherent cells were harvested and labeled
with 35S-methionine., Gels were run following lysis
and immunoprecipitation of the radio-labeled Ig. As
shown in Fig. 3, both types of LBMC were pro-
ducing multiple species of mu and light chains. The
transgenic LBMC were also synthesizing a mono-
clonal gamma chain corresponding to that encoded
by the transgene. It appeared that the presence of
the transgene did not restrict the synthesis of a
variety of mu and light chains, although there
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FIGURE 2. J, rearrangements of DNA from LBMC by Southern
blot. DNA (10/zg) from mouse liver (A), control LBMC (B), or
y2b transgenic LBMC after 5 weeks of culture (C) were digested
with EcoRI. Hybridization is with a JH probe; the unrearranged JH
germ-line band (GL) is shown on either side of the autoradio-
gram. The probe also hybridizes to the integrated transgene (TG).
seemed to be somewhat fewer species than syn-
thesized by the control cultures. This may indicate
pauciclonality due to selection of a subpopulation of
mu-producing pre-B cells.
To demonstrate that single cells from the trans-
genic LBMC were synthesizing mu, gamma, and
kappa chains, clonal lines were derived with
FIGURE 3. Two-dimensional gel electrophoresis of cell lysates. Equal numbers of cells from control (panel A) or y2b transgenic (panel
35 B) mouse-derived LBMC or an A-MuLV-derived clonal line from y2b transgenic LBMC (panel C) were labeled with S-methionine in
the presence of tunicamycin. Ig chains were analyzed in the first dimension by a pH 8-4 isoelectric focusing gel (left to right) and in the
second dimension on a NaDod SO4/10% polyacrylamide gel. Mu (M), gamma (G), and light chain (L) are shown.
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A-MuLV transformation and agar cloning. Copro-
duction of mu, gamma, and kappa were seen in five
of six lines, as evaluated by two-dimensional gel
analysis (Fig. 3, panel C). The sixth cell line did not
produce gamma heavy chain, and DNA analysis
showed deletion of the transgene (data not shown).
Thus, although the presence of the transgenic y2b
heavy chain appeared to delay rearrangement and
expression of endogenous Ig heavy chains, eventu-
ally cells were able to express heterogeneous mu
and kappa chains and often coexpressed these with
the transgenic y2b chains.
LBMC from y2b Transgenic Mice Have Sterile Mu
Transcription without TdT Expression
To address the mechanism of the delay in IgH gene
rearrangement and expression, two known inter-
mediate steps in this process were evaluated. First,
the production of germ-line Ig transcripts in the
early LBMC cells was monitored. The initial step of
the Ig gene recombination process is the transcrip-
tional activation of these genes (Yancopoulos and
Alt, 1986; Schuler et al., 1988). This presumably
reflects the accessibility of the Ig genes to the
recombinase enzymes. The presence of germ-line
transcripts would indicate the commitment of these
LBMC cells to the B-lymphocyte lineage.
Cytoplasmic mRNA was isolated from 5-6-week-
old LBMC derived from normal and y2b transgenic
bone marrow. This mRNA was analyzed by
Northern blotting following agarose-formaldehyde
gel electrophoresis. Hybridization with a mu Ig
heavy-chain consant region probe showed that the
transgenic LBMC cells contained transcripts of 3.0
and 1.9 kb, the size of sterile mu transcripts pro-
duced from unrearranged mu genes (Fig. 4, lane D
in the first panel) (Alt et al., 1982; Schuler et al.,
1988). These could be seen in the control cell line in
lane B, which is an A-MuLV transformant of bone
marrow from a severe combined immunodeficient
mouse that has two germ-line IgH (Denis un-
published). LBMC cells from the normal cultures
also contained sterile mu transcripts, but addition-
ally produced 2.7- and 2.4-kb transcripts indicative
of intact, rearranged mu heavy-chain mRNA (Figure
4, lane C in the first panel). These data would sug-
gest that the Ig genes in both of the LBMC-derived
cells were transcriptionally active, but only the
normal-littermate-derived cultures had recombined
to form functional mu heavy-chain genes at that
time.
Second, these same mRNAs were evaluated for
the presence of TdT, a molecularly cloned enzyme of
the recombinase process (Desiderio et al., 1984;
Landau et al., 1987). Following transcriptional acti-
vation of the IgH genes, recombinase enzymes
would be activated to effect recombination. Hybridi-
zation of the Northern blot with a TdT probe
(Landau et al., 1987) detected no TdT transcripts in
the LBMC cells derived from b transgenic mice
(Figure 4, panel 2). Control LBMC were highly posi-
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FIGURE 4. Northern blot analysis of RNA from LBMC. RNA was extracted from control and y2b transgenic LBMC after 5 weeks of
culture. 20/g of total RNA was loaded per lane RNA from the A-MuLV pre-B cell 18.8 in lane A, the A-MuLV pre-B cell from SCID
bone marrow in lane B, control LBMC in lane C, and y2b transgenic LBMC in lane D. Blot is probed with 712 (Rogers et al., 1980),
blot 2 with TdT (Landau et al., 1987), and blot 3 with a probe for BP-1 .(kindly provided by M. D. Cooper).110 K.A. DENIS et al.
tive as were early lymphoid-control cell lines tested.
The Northern blot was also probed for glyceralde-
hyde 3-phosphate dehydrogenase gene expression
(GAPDH; Piechazyk et al., 1984), used as a measure
of mRNA quantity and integrity. This demonstrated
equal amounts of mRNA in the control and trans-
genic LBMC-derived lanes (data not shown).
To determine if TdT in early T lymphocytes was
also decreased, mRNA was extracted from the thy-
muses of young y2b transgenic and normal lit-
termate mice. High TdT levels were observed in
both types of mice by Northern blot analysis (data
not shown). The y2b transgene is transcribed in
thymocytes (Tsang et al., 1988), but does not appear
to affect TdT expression in these cells by this analy-
sis.
Finally, the expression of BP-1, a specific marker
of early B lymphocytes important in their differen-
tiation (Cooper et al., 19B6) was evaluated. As
shown in Fig. 4, panel 3, the expression of BP-1 in
the LBMC derived from the bone marrow of y2b
transgenic mice was also markedly reduced com-
pared to control LBMC. Thus, the y2b gene
appeared to exert a more global effect on B-lympho-
cyte differentiation.
DISCUSSION
The processes of B-lymphocyte differentiation and Ig
gene expression are firmly intertwined. In this
paper, we have demonstrated that mice transgenic
for the y2b Ig heavy chain have an altered early
B-cell compartment in their bone marrow. A strong
effect on peripheral B cells is also seen in young y2b
transgenic mice. However, adult mice with the 343-1
y2b transgene have a relatively normal peripheral
B-cell phenotype (P. Roth and U.S., unpublished).
Even A-MuLV transformants of the bone marrow of
these mice were only slightly altered in their Ig
expression and gene rearrangement status (Table 2).
Isolation of the B-lymphocyte developmental com-
partment of these mice using long-term lym)hoid
cultures enabled us to view events that are rare or
short-lived in vivo and expand them for molecular
analysis. LBMC from the transgenic mice had
delayed expression of endogenous mu heavy chain.
Despite being transcriptionally active, the mu heavy-
chain locus was unable to rearrange efficiently in
these cultured cells during the first few weeks. This
may be the result of feedback inhibition on the
recombinase pathway enzymes exemplified by a
paucity of TdT expression. Indeed, preliminary
results by Northern blot analysis indicate that these
early transgenic LBMC cells have decreased expres-
sion compared to controls of a second recombinase
associated enzyme RAG-1 (Schatz et al., 1989;
Schatz and Baltimore, personal communication).
-At this early culture time point, the expression of
BP-1 molecules was also reduced. This may suggest
that the presence of an Ig transgene can affect dif-
ferentiation molecules other .than endogenous Ig and
the enzymes utilized in the Ig recombination and
expression pathway. This decrease in BP-1-
expressing cells was also observed in fresh bone
marrow from the y2b transgenic animals. After
several additional weeks of culture, the transgenic
LBMC were populated by cells that had successfully
rearranged and were expressing their mu heavy-
chain genes.
This delay in Ig expression could be due to
slowed differentiation of normal numbers of pre-
cursors or differentiation from decreased numbers of
precursors due to an inhibitory mechanism such as
toxicity of the y2b transgene in early cells. Despite
similar growth kinetics in,the normal and transgenic
LBMC, these cultures lack certain negative regula-
tory elements and cells are allowed to survive that
might be deleted in vivo. A parallel can be drawn
with LBMC derived from severe combined immuno-
deficient mice (SCID; Witte et al., 1987). The non-
adherent cells that developed in these cultures were
identical to control cultured cells in the expression
of a variety of surface markers. However, the SCID-
derived cells did not express Ig and had numerous
aberrant Ig gene rearrangements. These cells, which
must be selectively eliminated in the intact animal,
were allowed to proliferate in the LBMC environ-
ment. In the y2b transgenic mice, the B lymphocytes
with delayed Ig recombination are perhaps elimi-
nated in such a manner, making them difficult to
isolate from the intact animal and resulting in a
reduced pre-B-lymphocyte compartment. However,
in the LBMC, because of the absence of negative
regulation, the cells are permitted to live. The cells
that reach the periphery in the adult y2b transgenic
mice have either overcome this block in Ig gene
expression or arise from a different cell lineage.
Several y2b transgenic mouse lines appear to have
the same phenotype as the 343-1 line described here
(Lo, Roth, Doglio, and U.S., unpublished). However,
another line of y2b transgenic mice has a much
different phenotype, with reduced mu +B-cell
numbers in the periphery (Lo, Roth, Doglio, andEARLY B CELLS IN y2b TRANSGENIC MICE 111
U.S., unpublished). It will be of great interest to Metabolic Labeling, Immunoprecipitation, and Gel
examine the peripheral lymphoid cOmpartment of Electrophoresis
these animals and observed B-lymphocyte develop-
ment in the neonate and young adult.
MATERIALS AND METHODS
Transgenic Mice
The y2b transgenic mice have been described pre-
Metabolic labeling of the cultured cells with 35S-
methionine (Amersham, Arlington Heights, IL) in
the presence of tunicamycin (Sigma),immunoprecipi-
tation, with goat antimouse Ig (Boehringer
Mannheim Biochemicals, Indianapolis, IN), and
SDS-polyacrylamide or two-dimensional electro-
phoresis were performed, as previously described
(Denis et al., 1984).
viously (Tsang et al., 1988). In this study only, the Nucleic Acid Extraction and Analysis
343-1-13 line was utilized.
Fluorescence Analysis
Fresh bone marrow cells were harvested from y2b
Nucleic acids were extracted from tissues and cell
lines according to established procedures (Maniatis
et al., 1982; Davis et al., 1986). Southern blot analy-,
sis was performed, as previously described (Denis et
al., 1984). Northern blot analys!s was done as pre- transgenic and normal littermate mice and stained
with FITC-labeled reagents as described in Dorsh- viously described (Tsang et al., 1988). Nucleic acid
kind et al. (1986). BP-1 (a kind gift from M. D. probes used for these analyses are described in the
Cooper) staining was indirectly detected with anti- appropriate figure legends.
mouse y2a (Southern Biotech, Birmingham, AL);
B220 staining was detected with antirat Ig (Southern Immunoperoxidase Cell Staining
Biotech). IgM and IgG2b surface staining was
performed directly. Cells were analyzed on an Epics
V flow cytometer (Coulter, Hialeah, FL).
Abelson Murine Leukemia Virus (A-MuLV)
Tranformants
Bone marrow cells from gamma 2b transgenic mice
Cytocentrifuge preparations of cells were stained
with peroxidase-conjugated goat antimouse mu
heavy chain (Boehringer-Mannheim) or gamma
heavy chain (Kierkegaard and Perry Laboratories,
Gaithersburg, MD), as previously described (Dinis
et al., 1984).
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